A new free access paper published online before print in the journal JAMA Neurology, entitled, “Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function” (JAMA Neurol. Published online August 11, 2014. DOI: 10.1001/.jamaneurol.2014.2011) documents a 40-year-old African American man referred…
News
The California Supreme Court recently decided, by a 5-2 decision, that people with Alzheimer’s disease cannot be held responsible for injuries caused to their in-home caregivers, and that a prior awareness of this fact precludes a legal accusation, CBS News recently reported, quoting an Associated Press report. According…
Vitamin D, known as the sunshine vitamin due to its mechanism of production in the body, is usually associated with calcium absorption and bone health, but researchers are finding that vitamin D is strongly linked to the risk for Alzheimer’s disease and dementia. Dr. David Llewellyn, from the University…
Increasing incidence of Alzheimer’s Disease and other forms of senile dementia as the population demographic ages has raised general anxiety levels. It’s not entirely paranoia. Risk of developing Alzheimer’s doubles every five years after age 65. Toronto, Canada-based Cogniciti, Inc. cites a recent Brain Health Study (about which more…
Researchers at Yale School of Medicine have discovered a new drug compound with the capacity to reverse the brain deficits of Alzheimer’s disease (AD) in an animal model. In this month’s issue of PLoS Biology, in an article entitled, “Inhibitor of the Tyrosine Phosphatase STEP Reverses Cognitive Deficits…
A set of recent studies indicate that the rate of Alzheimer’s disease and other forms of dementia is decreasing in some of the wealthiest nations around the world — including the U.S. According to an article by David Green on The Legacy, research conducted in England,…
A simple test that measures how fast people walk and whether they have cognitive issues can determine how likely they are to develop dementia, which includes diseases such as Alzheimer’s, within 12 years. These are the conclusions of a study led by scientists at the Albert Einstein College of…
Recent results from Prana Biotechnology’s IMAGINE Alzheimer’s trial, released earlier this year (March), as well as the company’s ongoing sub-analysis, has suggested to the company’s research team that further analysis of the PiB-PET Standardized Uptake Value Ratio (SUVR) and the tendency towards preservation of brain volume in PBT2 treated patients may be necessary. The results…
Assertions of a potential link between Lyme disease and Alzheimer’s deaths have been shown baseless by new research at the University of Toronto Mississauga A U of T Mississauga release notes that while researching his book “The Alzheimer’s Epidemic—Searching for Causes and a Cure” (Emeritus Books),…
The onset of Alzheimer’s disease, as well as its symptoms, may be slowed down by a natural compound present in pomegranates, according to research conducted at the University of Huddersfield, in West Yorkshire, UK. During his two-year project, Dr. Olumayokun Olajide, a specialist in anti-inflammatory properties of natural…
Recent Posts
- FDA decision on AXS-05 for Alzheimer’s agitation expected April 30 January 6, 2026
- Oral semaglutide fails to slow Alzheimer’s in pair of clinical trials December 2, 2025
- Canada gives conditional OK to early Alzheimer’s drug Leqembi November 4, 2025
- Kisunla approval offers new option to treat early Alzheimer’s in Europe October 3, 2025
- Guest Voice: A journey through loss, love, and remembrance October 2, 2025